CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 14.12: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.90BCNY581.70M · vs all stocks (USD)
Revenue (TTM)
328.58MCNY49.01M · vs all stocks (USD)
Profit Margin
-2.83%Beta
0.0790xvs all stocks
52-Week Change
-11.80%vs all stocks
Market Capitalization
3.90BCNY581.70M · vs all stocks (USD)
Enterprise Value
3.35BCNY499.85M · vs all stocks (USD)
Price to Sales (TTM)
11.85xPrice to Book (MRQ)
3.48xEnterprise to Revenue
10.20xGross Margin
33.50%Profit Margin
-2.83%Operating Margin
3.10%Return on Assets (TTM)
-0.53%Return on Equity (TTM)
-0.83%Revenue (TTM)
328.58MCNY49.01M · vs all stocks (USD)
Revenue per Share (TTM)
0.4470CNYUpdated Sep 19, 2026Quarterly Revenue Growth
11.90%Gross Profit (TTM)
102.61MCNY15.31M · vs all stocks (USD)
EBITDA (TTM)
181.60MCNY27.09M · vs all stocks (USD)
Net Income (TTM)
-9.30MCNY-1.39M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-98.10%Operating Cash Flow (TTM)
-67.21MCNY-10.03M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-92.35MCNY-13.77M · vs all stocks (USD)
Payout Ratio
0.00%Revenue
323.14MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
216.14MCNYFY2025 · Dec 31, 2025Gross Profit
107.00MCNYFY2025 · Dec 31, 2025Operating Income
-12.24MCNY-1.83M · vs all stocks (USD)
Pre-tax Income
96.43MCNYFY2025 · Dec 31, 2025Income Tax Expense
124.51KCNYFY2025 · Dec 31, 2025Net Income
96.31MCNYFY2025 · Dec 31, 2025EBIT
131.14MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
184.21MCNYFY2025 · Dec 31, 2025Research & Development
15.47MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
43.98MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.58MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
8.74MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
34.70MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
740.83MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
740.83MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
96.31MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
139.04MCNYFY2025 · Dec 31, 2025Free Cash Flow
134.00MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
608.14MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
96.31MCNYFY2025 · Dec 31, 2025Other Non-cash Items
32.74MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
59.31MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-49.32MCNYFY2025 · Dec 31, 2025Capital Expenditures
-5.04MCNYFY2025 · Dec 31, 2025Net Acquisitions
174.78MCNYFY2025 · Dec 31, 2025Purchase of Investments
-60.00MCNYFY2025 · Dec 31, 2025Sale of Investments
62.29MCNYFY2025 · Dec 31, 2025Other Investing Activity
2.12MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
174.15MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-277.23MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-37.37MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-314.60MCNYFY2025 · Dec 31, 2025Shares Outstanding
745.67MSharesUpdated Sep 19, 2026Float Shares
597.75MSharesUpdated Sep 19, 2026% Held by Insiders
19.70%vs all stocks
% Held by Institutions
0.05%vs all stocks
Total Cash (MRQ)
515.38MCNY76.87M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.6910CNYUpdated Sep 19, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xCurrent Ratio (MRQ)
12.71xBook Value per Share (MRQ)
1.50CNYUpdated Sep 19, 2026Total Assets
1.28BCNY190.88M · vs all stocks (USD)
Total Current Assets
898.27MCNYFY2025 · Dec 31, 2025Total Liabilities
159.43MCNYFY2025 · Dec 31, 2025Total Non-current Assets
381.44MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
7.19MCNYFY2025 · Dec 31, 2025Total Current Liabilities
152.24MCNYFY2025 · Dec 31, 2025Cash
608.14MCNYFY2025 · Dec 31, 2025Cash Equivalents
10.58MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
618.72MCNYFY2025 · Dec 31, 2025Accounts Receivable
91.42MCNYFY2025 · Dec 31, 2025Inventory
107.25MCNYFY2025 · Dec 31, 2025Accounts Payable
103.97MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.92MCNYFY2025 · Dec 31, 2025Common Stock (Book)
745.67MCNYFY2025 · Dec 31, 2025Retained Earnings
-1.69BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.12BCNY167.10M · vs all stocks (USD)
52-Week Low
4.41CNYUpdated Sep 19, 202652-Week High
9.41CNYUpdated Sep 19, 202652-Week Change
-11.80%vs all stocks
Beta
0.0790xvs all stocks
50-Day MA
5.36CNYUpdated Sep 19, 2026200-Day MA
6.36CNYUpdated Sep 19, 2026Avg 10-Day Volume
21.04MSharesUpdated Sep 19, 2026Avg 30-Day Volume
33.88MSharesUpdated Sep 19, 2026Diluted EPS (TTM)
-0.0100CNYUpdated Sep 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 14.12: safe zoneNotable
Altman Z-Score: 14.12
High structural barrier to entryNotable
Barrier to Entry: 0.81
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
MapLight Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hainan Shuangcheng Pharmaceuticals Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tilray Brands, Inc.
Tier 1ProductionApproval-Gated PipelineFlowAttention
Qurient Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Gansu Longshenrongfa Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zeria Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Newland Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Sihuan Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Sunflower Great Health Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Sportradar Group AG
1 interpretationDrawdown With FCF And Cash Backing
Zhenjiang Dongfang Electric Co., Ltd.
1 interpretationDrawdown With FCF And Cash Backing
Fintel Plc
1 interpretationDrawdown With FCF And Cash Backing